Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Structured Computational Roadmap for Lipidomics in R: Reproducible Workflows from Raw Data to Functional Insight.

Metabolites·2026
Same author

AI agents in Alzheimer's disease management: challenges and future directions.

Frontiers in aging neuroscience·2026
Same author

Web-Based Application for Hashimoto's Disease Prediction Based on Thyroid Hormone Levels and Machine Learning Analysis.

Advances in experimental medicine and biology·2026
Same author

Comprehensive Differential Gene Expression Analysis in Glioblastoma Using PyDESeq2: A Comparison with Normal Brain Tissue.

Advances in experimental medicine and biology·2026
Same author

A Mathematical Model for the Variation of Cerebral Electrical Conductivity and the Amount of β-Amyloid Protein Values Due to Alzheimer's Disease.

Brain sciences·2025
Same author

Computational analysis of transcriptome data and mapping of functional networks in Parkinson's disease.

Frontiers in bioinformatics·2025

Related Experiment Video

Updated: Aug 13, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K

In Silico Structural Analysis Predicting the Pathogenicity of PLP1 Mutations in Multiple Sclerosis.

Antigoni Avramouli1, Marios G Krokidis1, Themis P Exarchos1

  • 1Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 491 00 Corfu, Greece.

Brain Sciences
|January 21, 2023
PubMed
Summary

Mutations in the PLP1 gene, linked to rare brain disorders, may also contribute to multiple sclerosis (MS) by altering myelin proteolipid protein structure and function, impacting therapeutic strategies.

Keywords:
functional analysismultiple sclerosismyelin proteolipid proteinprotein structure prediction

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.9K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.7K

Related Experiment Videos

Last Updated: Aug 13, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.9K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Computational Biology

Background:

  • The X chromosome gene PLP1 encodes myelin proteolipid protein (PLP), crucial for central nervous system myelin.
  • X-linked dysmyelinating disorders like Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia type 2 (SPG2) arise from PLP1 mutations.
  • Some PLP1 missense mutations present symptoms overlapping with multiple sclerosis (MS), a chronic neurological disease.

Purpose of the Study:

  • To investigate the impact of PLP1 mutations on PLP structure and function.
  • To explore the potential role of PLP1 mutations in the pathogenicity of multiple sclerosis (MS).
  • To identify potential therapeutic targets for MS based on PLP1 mutation effects.

Main Methods:

  • Computational structural biology methods were employed to analyze PLP structure stability and flexibility.
  • In silico genomic methods were used to predict the functional significance of PLP1 mutations.
  • Analysis focused on missense mutations identified in individuals with MS-like symptoms.

Main Results:

  • PLP1 variants were found to significantly alter protein structure and function.
  • Specific mutations, such as R137W, can lead to loss of helical structure.
  • The H140Y mutation was observed to disrupt the ordered protein interface, affecting protein interactions.

Conclusions:

  • PLP1 mutations can impair myelin proteolipid protein functionality, potentially contributing to MS.
  • Computational analyses provide insights into the molecular mechanisms underlying PLP1-associated neurological disorders.
  • Findings may inform the development of targeted therapeutic strategies for MS patients with specific genetic profiles.